PACB
Pacific Biosciences of California Inc

14,357
Loading...
Loading...
News
all
press releases
Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today
In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.17, denoting a -7.14% move from the preceding trading day.
Zacks·9d ago
News Placeholder
More News
News Placeholder
PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq
PacBio collaborates with EpiCypher to integrate Fiber-Seq and HiFi sequencing, advancing single-molecule epigenomics with new chromatin mapping tools.
Zacks·16d ago
News Placeholder
PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises
PACB stock jumps after Q2 results beat estimates, with narrow losses, rising margins, and strong global demand.
Zacks·1mo ago
News Placeholder
Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Pacific Biosciences (PACB) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·1mo ago
News Placeholder
Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of +27.78% and +9.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -20.00% and +0.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Stay Ahead of the Game With Pacific Biosciences (PACB) Q2 Earnings: Wall Street's Insights on Key Metrics
Beyond analysts' top-and-bottom-line estimates for Pacific Biosciences (PACB), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Zacks·2mo ago
News Placeholder
Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights
Pacific Biosciences of California (PACB) reached $1.54 at the closing of the latest trading day, reflecting a -6.1% change compared to its last close.
Zacks·2mo ago
News Placeholder
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know
Pacific Biosciences of California (PACB) reached $1.39 at the closing of the latest trading day, reflecting a -6.71% change compared to its last close.
Zacks·2mo ago
News Placeholder
Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know
The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.5, representing a +1.35% change from its previous close.
Zacks·2mo ago

Latest PACB News

View

Advertisement. Remove ads.

Advertisement. Remove ads.